CAL
XLRN

Capital Analysts LLC’s Acceleron Pharma XLRN Stock Holding History

Capital Analysts LLC’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-220
Closed -$38K – 1050
2021
Q3 		$38K Hold
220
– – ﹤0.01% 620
2021
Q2 		$28K Hold
220
– – ﹤0.01% 626
2021
Q1 		$30K Buy
+220
New +$28.4K ﹤0.01% 663

Capital Analysts LLC's XLRN Position: Q4 2021 in Review

Capital Analysts LLC sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 220 shares — an estimated $38K sold.

Capital Analysts LLC first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $38K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Capital Analysts LLC reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Capital Analysts LLC sold 220 Acceleron Pharma shares in Q4 2021, an estimated $38K.
  • Capital Analysts LLC first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
  • Capital Analysts LLC's Acceleron Pharma position peaked at $38K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Capital Analysts LLC's 13F filing for Q4 2021, filed 10 Feb 2022.